Study to use genetic testing to evaluate heart disease

By LabPulse.com staff writers

February 23, 2022 -- Dignity Health in Arizona is starting a research study that will use genetic testing to identify individuals at risk of developing heart disease.

Researchers from Dignity Health's Chandler Regional Medical Center, Mercy Gilbert Medical Center, and St. Joseph's Hospital and Medical Center will gather approximately 2,000 DNA samples from men and women between the ages of 40 and 60 with no known history of heart disease. The samples will be analyzed for genetic markers known to cause heart disease at Baylor College of Medicine's Human Genome Sequencing Center Clinical Lab in Houston.

Once the DNA genotyping is complete, the Dignity Health group will evaluate each study participant's risk of heart disease; other factors such as hypertension, diabetes, high cholesterol, and smoking history will also be assessed. Participants who wish to know their results will be notified, Dignity Health said.

Millions of diabetes blood tests missed during U.K. lockdown
Approximately 2.5 million diagnostic blood tests for diabetes were missed or delayed in the U.K. during COVID-19 lockdown, according to research presented...
Patients approve of medical screening at dental offices
Patients generally approve of getting general medical screening -- including blood pressure tests and lab tests -- at their dentists' offices, according...
Cardio Diagnostics debuts coronary heart disease test
Cardio Diagnostics has launched its patent-pending Epi+Gen CHD test, which is used to assess the risk for the onset of new coronary heart disease. The...
Heart association offers advice on who should get genetic testing
The American Heart Association has released a new scientific statement on genetic testing and counseling for inherited cardiovascular diseases, including...
Who stands to gain from polygenic risk scoring for heart disease?
Polygenic risk scoring may benefit some middle-aged people at borderline risk for cardiovascular events and has potential as a one-time test for those...

Copyright © 2022 LabPulse.com

Last Updated np 2/23/2022 4:29:22 PM